Hcw Biologics Stock Alpha and Beta Analysis
| HCWB Stock | USD 0.61 0.16 20.78% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as HCW Biologics. It also helps investors analyze the systematic and unsystematic risks associated with investing in HCW Biologics over a specified time horizon. Remember, high HCW Biologics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to HCW Biologics' market risk premium analysis include:
Beta (2.78) | Alpha 4.45 | Risk 42.1 | Sharpe Ratio 0.096 | Expected Return 4.04 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
HCW |
HCW Biologics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. HCW Biologics market risk premium is the additional return an investor will receive from holding HCW Biologics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in HCW Biologics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate HCW Biologics' performance over market.| α | 4.45 | β | -2.78 |
HCW Biologics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of HCW Biologics' Buy-and-hold return. Our buy-and-hold chart shows how HCW Biologics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.HCW Biologics Market Price Analysis
Market price analysis indicators help investors to evaluate how HCW Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading HCW Biologics shares will generate the highest return on investment. By understating and applying HCW Biologics stock market price indicators, traders can identify HCW Biologics position entry and exit signals to maximize returns.
HCW Biologics Return and Market Media
The median price of HCW Biologics for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 is 0.5 with a coefficient of variation of 29.93. The daily time series for the period is distributed with a sample standard deviation of 0.16, arithmetic mean of 0.53, and mean deviation of 0.1. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Greene Rick S. of 35714 shares of HCW Biologics at 1.4 subject to Rule 16b-3 | 09/18/2024 |
2 | HCW Biologics Inc. Short Interest Down 11.4 percent in October | 11/01/2024 |
3 | HCW Biologics reports Q3 results | 11/15/2024 |
4 | Broward pharma developer inks 7 million deal with Chinese firm | 11/18/2024 |
5 | Why Keysight Technologies Shares Are Trading Higher By Over 9 Here Are 20 Stocks Moving Premarket | 11/20/2024 |
About HCW Biologics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including HCW or other stocks. Alpha measures the amount that position in HCW Biologics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2010 | 2023 | 2024 (projected) | Dividend Yield | 0.034 | 0.0306 | 0.0272 | Price To Sales Ratio | 56.4 | 15.55 | 30.12 |
HCW Biologics Upcoming Company Events
As portrayed in its financial statements, the presentation of HCW Biologics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, HCW Biologics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of HCW Biologics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of HCW Biologics. Please utilize our Beneish M Score to check the likelihood of HCW Biologics' management manipulating its earnings.
| 26th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with HCW Biologics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out HCW Biologics Backtesting, HCW Biologics Valuation, HCW Biologics Correlation, HCW Biologics Hype Analysis, HCW Biologics Volatility, HCW Biologics History and analyze HCW Biologics Performance. For information on how to trade HCW Stock refer to our How to Trade HCW Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
HCW Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.